Volume 81, Issue 5, Pages (March 2012)

Slides:



Advertisements
Similar presentations
Volume 82, Issue 12, Pages (December 2012)
Advertisements

Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Volume 81, Issue 5, Pages (March 2012)
Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury  Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian,
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Incidence and Risk of Cardiac Events in Patients With Previously Treated Multiple Myeloma Versus Matched Patients Without Multiple Myeloma: An Observational,
Volume 83, Issue 3, Pages (March 2013)
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Volume 92, Issue 2, Pages (August 2017)
Prehypertension and chronic kidney disease: the ox or the plow?
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 80, Issue 11, Pages (December 2011)
Type of vascular access and mortality in U.S. hemodialysis patients
Sabina Kersting, Leo F. Verdonck 
Volume 82, Issue 12, Pages (December 2012)
Volume 78, Issue 8, Pages (October 2010)
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Ioannis Koulouridis, MD, MS, Lori Lyn Price, MAS, Nicolaos E
Volume 83, Issue 5, Pages (May 2013)
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 78, Issue 9, Pages (November 2010)
Comorbidity and confounding in end-stage renal disease
Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing?  Gautam R. Shroff, Charles A. Herzog 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Volume 77, Issue 7, Pages (April 2010)
Volume 77, Issue 2, Pages (January 2010)
The epidemiology of chronic kidney disease
Use of vitamin D in chronic kidney disease patients
Volume 75, Issue 1, Pages (January 2009)
U-shaped effect of eGFR and mortality
Volume 74, Issue 8, Pages (October 2008)
Etienne Macedo, Ravindra L. Mehta  American Journal of Kidney Diseases 
Volume 83, Issue 4, Pages (April 2013)
Volume 73, Issue 12, Pages (June 2008)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Alternate-day dialysis may be needed for hemodialysis patients
Methods for guideline development
Volume 76, Issue 8, Pages (October 2009)
Volume 78, Issue 5, Pages (September 2010)
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease  C.P. Kovesdy, S. Ahmadzadeh,
Volume 85, Issue 5, Pages (May 2014)
Volume 73, Issue 8, Pages (April 2008)
Perioperative Acute Kidney Injury
Volume 87, Issue 5, Pages (May 2015)
Cardio-Kidney-Damage: a unifying concept
Volume 81, Issue 7, Pages (April 2012)
Volume 70, Issue 7, Pages (October 2006)
Volume 80, Issue 10, Pages (November 2011)
Volume 75, Issue 1, Pages (January 2009)
Update on fibroblast growth factor 23 in chronic kidney disease
Importance of blood pressure control in hemodialysis patient survival
Volume 87, Issue 3, Pages (March 2015)
Volume 64, Issue 4, Pages (October 2003)
Volume 82, Issue 9, Pages (November 2012)
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 81, Issue 8, Pages (April 2012)
Volume 88, Issue 5, Pages (November 2015)
Volume 71, Issue 7, Pages (April 2007)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients  M.R. Marshall, B.G. Byrne, P.G. Kerr,
Rajni Singhal, Janet E. Hux, Shabbir M H Alibhai, Matthew J. Oliver 
Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system  Victoria A. Kumar, Margo A. Sidell,
Sugar-sweetened beverages and chronic disease
Presentation transcript:

Volume 81, Issue 5, Pages 477-485 (March 2012) Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury  Ion D. Bucaloiu, H Lester Kirchner, Evan R. Norfolk, James E. Hartle, Robert M. Perkins  Kidney International  Volume 81, Issue 5, Pages 477-485 (March 2012) DOI: 10.1038/ki.2011.405 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Unadjusted survival by exposure status (recovered acute kidney injury (AKI) group vs. controls) among patients with normal baseline kidney function. Kidney International 2012 81, 477-485DOI: (10.1038/ki.2011.405) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 Cumulative incidence of chronic kidney disease (CKD) by exposure status (recovered acute kidney injury (AKI) group vs. controls) among patients with normal baseline kidney function. Kidney International 2012 81, 477-485DOI: (10.1038/ki.2011.405) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 3 Cox proportional hazard survival (recovered acute kidney injury vs. controls) by cohort subgroups. These models were developed for each specified subgroup from the final matched cohort (n=1610 and 3652 cases and controls, respectively). Each model is adjusted for index hospital length of stay, as well as for the development of chronic kidney disease during follow-up, as in the primary analysis. CCI, Charlson Co-morbidity Index. Kidney International 2012 81, 477-485DOI: (10.1038/ki.2011.405) Copyright © 2012 International Society of Nephrology Terms and Conditions